About this document
Biotechnology Beta Analysis and WACC by Jesús Emmanuel Chuquispuma Sauñe is a document available to read on EtoBox.
The document provides financial information about the biotechnology industry. It includes unlevered and levered betas, market risk premium, debt to equity ratios, tax rates, and weighted average cost of capital (WACC). The average unlevered beta for biotechnology firms is 1.01, and the average levered beta is 2.66. The WACC for the sample firm is 14.82%.
- Author
- Jesús Emmanuel Chuquispuma Sauñe
- Language
- EN